HAMBURG, Germany – Startup company Pq Bypass Inc. has completed a round of funding that can provide up to an aggregate of $60 million in equity financing to be used to advance clinical develop of its Detour system, which treats long blockages in leg arteries caused by peripheral arterial disease. The goal of the company is to eventually win U.S. FDA clearance for the system.

HAMBURG, Germany – Paris-based company Curium has signed an exclusive agreement with U.S. firm Progenics Pharmaceuticals Inc. to develop and commercialize in Europe a small-molecule positron emission topography (PET) imaging agent designed by Progenics to visualize prostate cancer.

HAMBURG, Germany – Edwards Lifesciences Corp. received U.S. FDA approval to market its Sapien 3 Ultra system for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are at intermediate or greater risk of open-heart surgery.